Literature DB >> 14724462

Red blood cell physiology in critical illness.

Marion Scharte1, Mitchell P Fink.   

Abstract

OBJECTIVE: Reduction in red blood cell mass, as well as structural and functional alterations of erythrocytes, occurs in critical illness. This review discusses these changes in red blood cell physiology, emphasizing the pathogenesis of anemia in intensive care unit patients. DATA SOURCE: Studies published in biomedical journals. DATA SYNTHESIS AND
CONCLUSION: Anemia in intensive care unit patients resembles the anemia of chronic disease, being characterized by diminished erythropoietin production relative to decreased hematocrit, altered iron metabolism, and impaired proliferation and differentiation of erythroid progenitors in the bone marrow. Inflammatory mediators play a major role in the development of insufficient erythropoiesis and altered iron metabolism. Furthermore, a proinflammatory milieu promotes structural and functional alterations of erythrocytes, impairing their deformability and possibly impairing microvascular perfusion. Collectively, these changes in red blood cell physiology can impair oxygen transport to tissues and, thereby, might contribute to the development of multiple organ failure in critical illness.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14724462     DOI: 10.1097/01.CCM.0000098036.90796.ED

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  41 in total

1.  The impact of anemia in moderate to severe traumatic brain injury.

Authors:  O Okoye; K Inaba; M Kennedy; A Salim; P Talving; D Plurad; L Lam; D Demetriades
Journal:  Eur J Trauma Emerg Surg       Date:  2013-06-18       Impact factor: 3.693

2.  Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry.

Authors:  Jenn-Han Chen; Yu-Wang Chang; Chen-Wen Yao; Tzong-Shi Chiueh; Su-Chin Huang; Ko-Yi Chien; An Chen; Feng-Yee Chang; Chi-Huey Wong; Yu-Ju Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-30       Impact factor: 11.205

3.  Direct bilirubin as a prognostic biomarker in enteric fistula patients complicated with sepsis: a case-control study.

Authors:  Yin Wu; Jianan Ren; Gefei Wang; Guosheng Gu; Bo Zhou; Chao Ding; Guanwei Li; Song Liu; Xiuwen Wu; Jun Chen; Jieshou Li
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  Anemia of aging: the role of chronic inflammation and cancer.

Authors:  Luigi Ferrucci; Lodovico Balducci
Journal:  Semin Hematol       Date:  2008-10       Impact factor: 3.851

5.  Prognostic significance of red cell distribution width and its relation to increased pulmonary pressure and inflammation in acute heart failure.

Authors:  Ryszard Targoński; Janusz Sadowski; Magdalena Starek-Stelmaszczyk; Radosław Targoński; Andrzej Rynkiewicz
Journal:  Cardiol J       Date:  2018-09-20       Impact factor: 2.737

Review 6.  RBC Transfusion Strategies in the ICU: A Concise Review.

Authors:  Casey A Cable; Seyed Amirhossein Razavi; John D Roback; David J Murphy
Journal:  Crit Care Med       Date:  2019-11       Impact factor: 7.598

Review 7.  Prevalence, severity, and pathogeneses of anemia in visceral leishmaniasis.

Authors:  Yasuyuki Goto; Jingjie Cheng; Satoko Omachi; Ayako Morimoto
Journal:  Parasitol Res       Date:  2016-11-07       Impact factor: 2.289

Review 8.  Liver involvement in systemic infection.

Authors:  Masami Minemura; Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Hepatol       Date:  2014-09-27

9.  Cell-free hemoglobin: a novel mediator of acute lung injury.

Authors:  Ciara M Shaver; Cameron P Upchurch; David R Janz; Brandon S Grove; Nathan D Putz; Nancy E Wickersham; Sergey I Dikalov; Lorraine B Ware; Julie A Bastarache
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-15       Impact factor: 5.464

Review 10.  Anemia and red blood cell transfusion in neurocritical care.

Authors:  Andreas H Kramer; David A Zygun
Journal:  Crit Care       Date:  2009-06-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.